Summit Therapeutics
SMMT
#1552
Rank
S$18.13 B
Marketcap
S$22.68
Share price
8.51%
Change (1 day)
-4.78%
Change (1 year)

Summit Therapeutics (SMMT) - Net assets

Net assets on the balance sheet as of June 2026 : S$0.80 Billion

According to Summit Therapeutics 's latest financial reports the company has S$0.80 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Summit Therapeutics - Net assets on balance sheet (from 2020 to 2020)

Net assets by year

Year Net assets Change
2023-12-31$S$0.10 B-39.57%
2022-12-31$S$0.16 B50.8%
2021-12-31$S$0.11 B7.12%
2020-12-31$S$0.10 B
2019-01-31$S$98.52 M-1289.29%
2018-01-31$-S$8.29 Million6.88%
2017-01-31$-S$7.76 Million-116.68%
2016-01-31$S$46.45 M16.47%
2015-01-31$S$39.88 M141.49%
2014-01-31$S$16.51 M87.87%
2013-01-31$S$8.79 M17.83%
2012-01-31$S$7.46 M-37.09%
2011-01-31$S$11.86 M-60.07%
2010-01-31$S$29.7 M12.43%
2009-01-31$S$26.41 M-82.68%
2008-01-31$S$0.15 B26.12%
2007-01-31$S$0.12 B79.2%
2006-01-31$S$67.49 M-17.47%
2005-01-31$S$81.78 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Sarepta Therapeutics
SRPT
S$1.95 B 142.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
S$0.28 B-64.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
S$77.85 M-90.34%๐Ÿ‡บ๐Ÿ‡ธ USA